NEW YORK, May 12 Reportlinker.com announces that a new market research report is available in its catalogue:
Sleep Aids: Technologies and Global Markets
Advertisement
http://www.reportlinker.com/p0196575/Sleep-Aids-Technologies-and-Global-Markets.html
THIS REPORT
Information about sleep aids, including prescription, over-the-counter medications, sleep apnea devices, mattresses and pillows, and sleep labs
Advertisement
Analysis of the U.S. market, including data for 2008, estimates for 2009, and projections, with compound annual growth rates (CAGRs), through 2014
Discussion of the market's growth due to an aging population, increasing stress in everyday life, and new advancements in the sleeping arena
Focus on research and development for sleep-aid medications
Comprehensive company profiles.
Chapter- 1: INTRODUCTION -- Complimentary
STUDY GOALS AND OBJECTIVES 1
REASONS FOR STUDY 1
SCOPE OF STUDY 1
METHODOLOGY AND INFORMATION SOURCES 2
ANALYST CREDENTIALS 2
RELATED BCC REPORTS 2
BCC ONLINE SERVICES 3
DISCLAIMER 3
Chapter-2: EXECUTIVE SUMMARY
EXECUTIVE SUMMARY 4
EXECUTIVE SUMMARY (CONTINUED) 5
EXECUTIVE SUMMARY (CONTINUED) 6
SUMMARY TABLE A TOTAL WORLDWIDE MARKET FOR SLEEP AIDS BY PRODUCT TYPE, THROUGH 2014 ($ MILLIONS) 7
SUMMARY TABLE B WORLDWIDE MARKET FOR SLEEP AIDS: TECHNOLOGIES AND MARKETS BY REGION, 2008-2014 (%) 8
SUMMARY FIGURE PERCENT OF TOTAL WORLDWIDE MARKET FOR SLEEP AIDS: TECHNOLOGIES AND MARKETS BY REGION, 2014 (%) 8
Chapter-3: INDUSTRY OVERVIEW
PHYSIOLOGY OF SLEEP 9
STAGES OF SLEEP 9
NREM Sleep 10
Stage 1 10
Stage 2 10
Stage 3 10
Stage 4 10
REM Sleep 11
SLEEP CYCLE 12
BIOLOGICAL CLOCK 12
FACTORS AFFECTING SLEEP 13
COMFORT LEVEL 13
ANXIETY AND STRESS 13
CULTURAL NORMS 13
DRUGS/MEDICATIONS 14
ENVIRONMENT 14
HORMONES 14
LIFESPAN CONSIDERATIONS 14
Lifespan Considerations (Continued) 15
LIFESTYLE 16
NUTRITION/DIET 16
ALTERATION IN SLEEP PATTERNS 16
INSOMNIA 17
Psychological Insomnia 17
Idiopathic Insomnia 17
Sleep-State Misinterpretation 18
NARCOLEPSY/HYPERSOMNIA 18
SLEEP APNEA AND SNORING 18
PARASOMNIA 19
SLEEP DEPRIVATION 20
DEMOGRAPHICS 20
TABLE 1 WORLD POPULATION BY SELECTED GEOGRAPHICAL REGION, 2008-2050 (MILLIONS) 21
TABLE 2 ESTIMATED WORLD POPULATION BY AGE AND GEOGRAPHICAL REGION, 2008 (MILLIONS) 21
TABLE 2 (CONTINUED) 22
TABLE 3 PERCENTAGE OF WORLDWIDE POPULATION OVER 65 BY YEAR AND REGION, 2008-2050 (%) 22
FIGURE 1 PERCENTAGE OF WORLDWIDE POPULATION OVER 65 BY YEAR AND REGION, 2008-2050 (%) 23
PREVALENCE OF SLEEP APNEA 24
TABLE 4 PREVALENCE OF SLEEP APNEA WORLDWIDE BY REGION AND COUNTRY, 2006 24
TABLE 4 (CONTINUED) 25
TABLE4 (CONTINUED) 26
TABLE 4 (CONTINUED) 27
OTHER SLEEP DISORDER STATISTICS 27
TABLE 5 U.S. OTHER SLEEP DISORDER STATISTICS 2008 27
NARCOLEPSY 28
RESTLESS LEG SYNDROME 29
SUBSTANCE ABUSE AND SLEEP DISORDERS 29
ALTERNATIVE SNORING AIDS 30
ALTERNATIVE SNORING AIDS (CONTINUED) 31
REIMBURSEMENT 32
SLEEP AND THE ELDERLY 33
DROWSY DRIVING 33
HOME TESTING 34
HOME TESTING (CONTINUED) 35
OTHER SLEEP PRODUCTS 36
OBESITY AND SLEEP PROBLEMS 37
INNOVATIVE COST-SAVING PROGRAMS 38
INNOVATIVE COST-SAVING PROGRAMS (CONTINUED) 39
Chapter-4: MARKET SIZE AND GROWTH
SLEEP MEDICATIONS MARKET 40
PRESCRIPTION 40
Benzodiazepines 40
ProSom 41
Dalmane 41
Doral 42
Restoril 42
Halcion 42
Nonbenzodiazepines 43
Lunesta 43
Ambien 44
Sonata 44
Melatonin Receptor Agonists 45
Rozerem 45
Narcolepsy Treatment 46
Provigil 46
Restless Leg Syndrome 46
ReQuip 46
Mirapex 46
Neupro 47
TABLE 6 GLOBAL SELECTED MARKETED PRESCRIPTION SLEEP AIDS, 2008 ($ MILLIONS) 47
TABLE 6 (CONTINUED) 48
OTC 48
Medications 48
Medications (Continued) 49
TABLE 7 GLOBAL SELECTED MARKETED OTC SLEEP AIDS, 2008 ($ MILLIONS) 50
Natural Remedies 50
Herbs 50
Melatonin 51
Tryptophan, L-tryptophan 51
New Over-the-Counter Sleep Aids 51
New Over-the-... (Continued) 52
SLEEP MEDICATION MARKET SIZE AND FORECAST 53
TABLE 8 GLOBAL MARKET FOR SLEEP AID MEDICATIONS AT MANUFACTURERS' SALES LEVELS, THROUGH 2014 ($ MILLIONS) 54
FIGURE 2 GLOBAL MARKET FOR SLEEP AID MEDICATIONS AT MANUFACTURERS' SALES LEVELS, THROUGH 2014 ($ MILLIONS) 54
TABLE 9 GLOBAL MARKET FOR PRESCRIPTION SLEEP AID MEDICATIONS BY TYPE AT MANUFACTURERS' SALES LEVELS, THROUGH 2014 ($ MILLIONS) 55
FIGURE 3 GLOBAL MARKET FOR PRESCRIPTION SLEEP AID MEDICATIONS BY TYPE AT MANUFACTURERS' SALES LEVELS, THROUGH 2014 ($ MILLIONS) 56
TABLE 10 GLOBAL MARKET FOR OTC SLEEP AID MEDICATIONS BY DRUG CLASS AT MANUFACTURERS' SALES LEVELS, THROUGH 2014 ($ MILLIONS) 57
FIGURE 4 GLOBAL MARKET FOR OTC SLEEP AID MEDICATIONS BY DRUG CLASS AT MANUFACTURERS' SALES LEVELS, 2008-2014 ($ MILLIONS) 57
United States 58
European Union 58
Japan 58
Rest of World 59
TABLE 11 GLOBAL MARKET FOR SLEEP AID MEDICATIONS BY REGION, THROUGH 2014 ($ MILLIONS) 59
FIGURE 5 GLOBAL MARKET FOR SLEEP AID MEDICATIONS BY REGION, 2008-2014 ($ MILLIONS) 60
TABLE 12 GLOBAL PERCENTAGE OF MARKET FOR SLEEP AID MEDICATIONS BY REGION, 2008-2014 (%) 60
FIGURE 6 GLOBAL PERCENTAGE OF MARKET FOR SLEEP AID MEDICATIONS BY REGION, 2008-2014 (%) 61
COMPETITIVE ANALYSIS OF THE PRESCRIPTION AND OTC SLEEP AID MEDICATIONS MARKET 61
TABLE 13 GLOBAL COMPETITIVE ANALYSIS OF PRESCRIPTION AND OTC SLEEP AIDS BY DRUG MANUFACTURER REVENUES AND MARKET SHARE, 2009 ($ MILLIONS/%) 62
FIGURE 7 GLOBAL COMPETITIVE ANALYSIS OF PRESCRIPTION AND OTC SLEEP AIDS BY DRUG MANUFACTURER REVENUES, 2009 ($ MILLIONS) 63
SLEEP APNEA DEVICES MARKET 63
SLEEP APNEA 63
Obstructive Sleep Apnea 64
Obstructive Sleep Apnea (Continued) 65
Obstructive Sleep Apnea (Continued) 66
Obstructive Sleep Apnea (Continued) 67
Obstructive Sleep Apnea (Continued) 68
Central Apnea 69
Central Apnea (Continued) 70
Mixed Apnea 71
SLEEP APNEA THERAPEUTIC EQUIPMENT 71
Flow Generators 71
CPAP Devices 72
Bi-Level PAP Devices 72
APAP Devices 72
Facial Interfaces 72
SLEEP APNEA DEVICE MARKET SIZE AND FORECAST 73
TABLE 14 GLOBAL MARKET FOR SLEEP APNEA DEVICES, THROUGH 2014 ($ MILLIONS) 73
United States 74
European Union 74
Japan 74
Rest of World 74
TABLE 15 GLOBAL MARKET FOR SLEEP APNEA DEVICES BY REGION, THROUGH 2014 ($ MILLIONS) 75
FIGURE 8 GLOBAL MARKET FOR SLEEP APNEA DEVICES BY REGION, 2008-2014 ($ MILLIONS) 75
TABLE 16 GLOBAL MARKET FOR SLEEP APNEA DEVICES BY REGION, 2008-2014 (%) 76
COMPETITIVE ANALYSIS OF THE SLEEP APNEA DEVICES MARKET 76
TABLE 17 COMPETITIVE ANALYSIS OF SLEEP APNEA DEVICE MANUFACTURERS WITH GLOBAL MARKET SHARES AND REVENUES, 2009 ($ MILLIONS/%) 77
FIGURE 9 COMPETITIVE ANALYSIS OF SLEEP APNEA DEVICE MANUFACTURERS WITH GLOBAL MARKET SHARES, 2009 (%) 77
SLEEP LABORATORIES MARKET 78
BACKGROUND OF SLEEP LABORATORIES 78
SLEEP LAB PROTOCOLS 78
Polysomnogram 79
Split Night Study 80
Multiple Sleep Latency Test 80
CPAP Titration Study 81
SLEEP LABORATORIES MARKET SIZE AND FORECAST 81
TABLE 18 GLOBAL MARKET FOR SLEEP LABORATORIES BY REGION, THROUGH 2014 ($ MILLIONS) 82
FIGURE 10 GLOBAL MARKET FOR SLEEP LABORATORIES BY REGION, 2008-2014 ($ MILLIONS) 82
TABLE 19 GLOBAL MARKET FOR SLEEP LABORATORIES BY REGION, THROUGH 2014 (%) 83
FIGURE 11 GLOBAL MARKET FOR SLEEP LABORATORIES BY REGION, 2014 (%) 83
MATTRESS AND PILLOW MARKET 84
MATTRESSES 84
Innerspring 84
Foam 84
Air Beds 84
Air Beds (Continued) 85
PILLOWS 86
Bed Pillows 87
Orthopedic Pillows 88
Decorative 88
Decorative (Continued) 89
MATTRESS AND PILLOW MARKET SIZE AND FORECAST 90
TABLE 20 GLOBAL MARKET FOR MATTRESSES AND PILLOWS, THROUGH 2014 ($ MILLIONS) 90
FIGURE 12 GLOBAL MARKET FOR MATTRESSES AND PILLOWS, 2008-2014 ($ MILLIONS) 91
TABLE 21 GLOBAL MARKET FOR MATTRESSES AND PILLOWS BY REGION, THROUGH 2014 ($ MILLIONS) 92
FIGURE 13 GLOBAL MARKET FOR MATTRESSES AND PILLOWS BY REGION, 2008-2014 ($ MILLIONS) 92
TABLE 22 GLOBAL MARKET FOR MATTRESSES AND PILLOWS BY REGION, 2008-2014 (%) 93
FIGURE 14 GLOBAL MARKET FOR MATTRESSES AND PILLOWS BY REGION, 2014 (%) 93
COMPETITIVE ANALYSIS OF THE MATTRESS AND PILLOW MARKET 94
Competitive Analysis of the Mattress ... (Continued) 94
TABLE 23 GLOBAL COMPETITIVE ANALYSIS OF MATTRESS AND PILLOW MANUFACTURERS WITH MARKET SHARES AND REVENUES, 2009 ($ MILLIONS/%) 95
FIGURE 15 GLOBAL COMPETITIVE ANALYSIS OF MATTRESS AND PILLOW MANUFACTURERS REVENUES, 2009 ($ MILLIONS) 95
Chapter-5: RESEARCH AND DEVELOPMENT
RECENT APPROVALS 96
EDLUAR 96
ZOLPIMIST 96
AWAITING APPROVAL 97
CILTYRI 97
INDIPLON 97
INTERMEZZO 97
SILENOR 97
SOLZIRA 98
PHASE III 98
ALMOREXANT 98
NUVIGIL 99
VEC-162 (TASIMELTEON) 99
TABLE 24 DRUGS IN DEVELOPMENT WORLDWIDE FOR SLEEP DISORDERS, 2009 100
TABLE 24 (CONTINUED) 101
NEW DEVELOPMENTS 101
MARKET SUMMARY 102
TOTAL MARKET 102
TABLE 25 GLOBAL MARKET FOR SLEEP AIDS: TECHNOLOGIES AND MARKETS, THROUGH 2014 ($ MILLIONS) 102
TOTAL MARKET BY PRODUCT TYPE 102
TABLE 26 GLOBAL MARKET FOR SLEEP AIDS BY PRODUCT TYPE, THROUGH 2014 ($ MILLIONS) 103
FIGURE 16 GLOBAL MARKET FOR SLEEP AIDS BY PRODUCT TYPE, 2008-2014 ($ MILLIONS) 104
FIGURE 17 GLOBAL MARKET FOR SLEEP AIDS BY PRODUCT TYPE, 2009 (%) 104
FIGURE 17 (CONTINUED) 105
TOTAL MARKET BY GEOGRAPHIC REGION 105
TABLE 27 GLOBAL MARKET FOR SLEEP AIDS: TECHNOLOGIES AND MARKETS BY REGION, THROUGH 2014 ($ MILLIONS) 106
FIGURE 18 GLOBAL MARKET FOR SLEEP AIDS: TECHNOLOGIES AND MARKETS BY REGION, THROUGH 2014 ($ MILLIONS) 106
TABLE 28 GLOBAL MARKET FOR SLEEP AIDS: TECHNOLOGIES AND MARKETS BY REGION, 2008-2014 (%) 107
FIGURE 19 GLOBAL MARKET FOR SLEEP AIDS: TECHNOLOGIES AND MARKETS BY REGION, 2008-2014 (%) 107
TOTAL COMPETITIVE ANALYSIS OF THE SLEEP AIDS MARKET 108
TABLE 29 TOP COMPETITORS IN SLEEP AIDS: TECHNOLOGIES AND GLOBAL MARKETS, 2009 ($ MILLIONS/%) 108
FIGURE 20 TOP COMPETITORS IN SLEEP AIDS: TECHNOLOGIES AND GLOBAL MARKETS, 2009 (%) 108
INDUSTRY PARTICIPANTS BY PRODUCT TYPE 109
TABLE 30 SELECTED SLEEP AID DISORDERS TREATMENT MANUFACTURERS BY TYPE, 2009 109
TABLE 30 (CONTINUED) 110
Chapter-6: COMPANY PROFILES
CADWELL LABORATORIES, INC. 111
BRIEF HISTORY 111
PRODUCTS 111
COMPANY REVENUE HISTORY 112
CAREFUSION CORP. 112
BRIEF HISTORY 112
PRODUCTS 112
COMPANY REVENUE HISTORY 112
TABLE 31 COMPANY REVENUES, 2008 AND 2009 112
CEPHALON, INC. 113
BRIEF HISTORY 113
PRODUCTS 113
COMPANY REVENUE HISTORY 114
TABLE 32 COMPANY REVENUES, 2008 AND 2009 ($ MILLIONS) 114
COMPUMEDICS, LTD. AUSTRALIA 114
BRIEF HISTORY 115
PRODUCTS 115
COMPANY REVENUE HISTORY 115
TABLE 33 COMPANY REVENUES, 2008 AND 2009 ($ MILLIONS) 116
DEVILBISS HEALTHCARE 116
BRIEF HISTORY 116
PRODUCTS 116
COMPANY REVENUE HISTORY 116
EMBLA SYSTEMS 117
BRIEF HISTORY 117
PRODUCTS 117
COMPANY REVENUE HISTORY 118
FISHER & PAYKEL 118
BRIEF HISTORY 118
PRODUCTS 118
COMPANY REVENUE HISTORY 118
TABLE 34 COMPANY REVENUES, 2008 AND 2009 ($ MILLIONS) 119
GLAXOSMITHKLINE 119
BRIEF HISTORY 119
PRODUCTS 119
COMPANY REVENUE HISTORY 120
TABLE 35 COMPANY REVENUES, 2008 AND 2009 ($ MILLIONS) 120
JOHNSON & JOHNSON 120
BRIEF HISTORY 120
PRODUCTS 121
COMPANY REVENUE HISTORY 121
TABLE 36 COMPANY REVENUES, 2008 AND 2009 ($ BILLIONS) 121
KING PHARMACEUTICALS, INC. 121
BRIEF HISTORY 121
PRODUCTS 122
COMPANY REVENUE HISTORY 122
TABLE 37 COMPANY REVENUES, 2008 AND 2009 ($ MILLIONS) 122
MERCK & CO., INC. 123
BRIEF HISTORY 123
PRODUCTS 123
COMPANY REVENUE HISTORY 123
TABLE 38 COMPANY REVENUES 2007 AND 2008 ($ MILLIONS) 123
NATUS MEDICAL, INC. 124
BRIEF HISTORY 124
PRODUCTS 124
COMPANY REVENUE HISTORY 124
TABLE 39 COMPANY REVENUES, 2008 AND 2009 ($ MILLIONS) 124
NEUROCRINE BIOSCIENCES, INC. 125
BRIEF HISTORY 125
PRODUCTS 125
COMPANY REVENUE HISTORY 125
TABLE 40 COMPANY REVENUES, 2008 AND 2009 ($ MILLIONS) 125
NOVADEL PHARMA, INC. 126
BRIEF HISTORY 126
PRODUCTS 126
COMPANY REVENUE HISTORY 126
TABLE 41 COMPANY REVENUES, 2008 AND 2009 ($ MILLIONS) 126
PFIZER, INC. 127
BRIEF HISTORY 127
PRODUCTS 127
COMPANY REVENUE HISTORY 127
TABLE 42 COMPANY REVENUES, 2008 AND 2009 ($ MILLIONS) 128
PHILIPS RESPIRONICS, INC. 128
BRIEF HISTORY 128
PRODUCTS 129
COMPANY REVENUE HISTORY 130
TABLE 43 COMPANY REVENUES, 2008 AND 2009 ($ MILLIONS) 130
RESMED, INC. 130
BRIEF HISTORY 130
PRODUCTS 131
COMPANY REVENUE HISTORY 131
TABLE 44 COMPANY REVENUES, 2008 AND 2009 ($ MILLIONS) 131
SANOFI-AVENTIS 132
BRIEF HISTORY 132
PRODUCTS 132
COMPANY REVENUE HISTORY 133
TABLE 45 COMPANY REVENUES, 2008 AND 2009 ($ MILLIONS) 133
SEALY CORP. 134
BRIEF HISTORY 134
PRODUCTS 134
COMPANY REVENUE HISTORY 135
TABLE 46 COMPANY REVENUES, 2008 AND 2009 ($ MILLIONS) 135
SELECT COMFORT CORP. 135
BRIEF HISTORY 135
PRODUCTS 135
COMPANY REVENUE HISTORY 136
TABLE 47 COMPANY REVENUES, 2008 AND 2009 ($ MILLIONS) 136
SEPRACOR, INC. 136
BRIEF HISTORY 136
PRODUCTS 137
COMPANY REVENUE HISTORY 137
TABLE 48 COMPANY REVENUES, 2008 AND 2009 ($ MILLIONS) 137
SLEEPMED, INC. 138
BRIEF HISTORY 138
PRODUCTS 138
COMPANY REVENUE HISTORY 138
SOMAXON PHARMACEUTICALS, INC. 138
BRIEF HISTORY 139
PRODUCTS 139
COMPANY REVENUE HISTORY 140
TABLE 49 COMPANY REVENUES, 2008 AND 2009 ($ MILLIONS) 140
TEMPUR-PEDIC INTERNATIONAL, INC. 140
BRIEF HISTORY 140
PRODUCTS 141
COMPANY REVENUE HISTORY 141
TABLE 50 COMPANY REVENUES, 2008 AND 2009 ($ MILLIONS) 142
UCB, INC. 142
BRIEF HISTORY 142
PRODUCTS 143
COMPANY REVENUE HISTORY 144
TABLE 51 COMPANY REVENUES, 2008 AND 2009 ($ MILLIONS) 144
VANDA PHARMACEUTICALS, INC. 144
BRIEF HISTORY 144
PRODUCTS 144
COMPANY REVENUE HISTORY 145
TABLE 52 COMPANY REVENUES, 2008 AND 2009 ($ MILLIONS) 145
XENOPORT, INC. 145
BRIEF HISTORY 145
PRODUCTS 146
COMPANY REVENUE HISTORY 146
TABLE 53 COMPANY REVENUES, 2008 AND 2009 ($ MILLIONS) 146
Chapter-7: APPENDIX
APPENDIX A 147
SLEEP ASSOCIATIONS 147
AMERICAN ACADEMY OF SLEEP MEDICINE 147
AMERICAN SLEEP APNEA ASSOC. 147
AMERICAN SLEEP DISORDERS ASSOCIATIONS (ASDA) 148
INTERNATIONAL SLEEP PRODUCTS ASSOC. (ISPA) 148
NARCOLEPSY NETWORK, INC. 148
NATIONAL CENTER ON SLEEP DISORDERS RESEARCH (NCSDR) 148
NATIONAL FOUNDATION FOR SLEEP AND RELATED DISORDERS IN CHILDEN (NFSRDC) 149
NATIONAL HEART, LUNG AND BLOOD INSTITUTE (NHLBI) 149
NATIONAL SLEEP FOUNDATION 149
SLEEP MEDICINE RESEARCH FOUNDATION, INC. 149
APPENDIX B 150
TABLE 54 LIST OF PARTICIPATING COMPANIES 150
To order this report:
Drug and Medication Industry: Sleep Aids: Technologies and Global Markets
More Market Research Report
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg Reportlinker Email: [email protected] US: (805)652-2626 Intl: +1 805-652-2626
SOURCE Reportlinker
